A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen
- Resource Type
- Article
- Authors
- Karmali, Reem; Galvez, Carlos; Hamadani, Mehdi; Gordon, Leo; Winter, Jane; Ma, Shuo; Nelson, Valerie; Fenske, Timothy S.; Shah, Nirav N.; Jagadeesh, Deepa; Klein, Andreas; Helenowski, Irene; Chen, Ruohui; Mi, Xinlei; Petrich, Adam; Evens, Andrew M.; Pro, Barbara
- Source
- In Blood Advances 9 April 2024 8(7):1612-1620
- Subject
- Clinical Trials and Observations
- Language
- ISSN
- 2473-9529